Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Maija Itälä-Remes"'
Autor:
David Michonneau, Raynier Devillier, Mikko Keränen, Marie Thérèse Rubio, Malin Nicklasson, Hélène Labussière-Wallet, Martin Carre, Anne Huynh, Elisabet Viayna, Montserrat Roset, Jonathan Finzi, Minja Pfeiffer, Daniel Thunström, Núria Lara, Lorenzo Sabatelli, Patrice Chevallier, Maija Itälä-Remes
Publikováno v:
Hematology Reports, Vol 16, Iss 2, Pp 283-294 (2024)
Acute graft-versus-host disease (aGVHD) remains a barrier to successful allogeneic hematopoietic stem cell transplantation (HSCT) outcomes. Contemporary comprehensive analyses of real-world clinical outcomes among patients who develop aGVHD post-HSCT
Externí odkaz:
https://doaj.org/article/c19848b2870645c89972a7581c0e60e1
Autor:
Atte K Lahtinen, Jessica Koski, Jarmo Ritari, Kati Hyvärinen, Satu Koskela, Jukka Partanen, Kim Vettenranta, Minna Koskenvuo, Riitta Niittyvuopio, Urpu Salmenniemi, Maija Itälä-Remes, Kirsi Jahnukainen, Outi Kilpivaara, Ulla Wartiovaara- Kautto, Maarja Karu
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100058- (2023)
Externí odkaz:
https://doaj.org/article/00460f5941584e5d97b84798c1738c14
Autor:
Sari Kytölä, Ida Vänttinen, Heikki Kuusanmäki, Tanja Ruokoranta, Mika Kurkela, Johanna Kiiski, Annasofia Holopainen, Anu Partanen, Milla E.L. Kuusisto, Sirpa Koskela, Riikka Räty, Maija Itälä-Remes, Pia Ettala, Johanna Rimpiläinen, Timo Siitonen, Marja Pyörälä, Janne T. Backman, Mikko Niemi, Mika Kontro
Publikováno v:
HemaSphere, Vol 7, p e53119c1 (2023)
Externí odkaz:
https://doaj.org/article/2f819d817a31442ca22a448adf20a3b5
Autor:
Mohamed A. Kharfan-Dabaja, Myriam Labopin, Ernesto Ayala, Ali Bazarbachi, Didier Blaise, Jan Vydra, Stefania Bramanti, Maija Itälä-Remes, Christoph Schmid, Alessandro Busca, Edouard Forcade, Werner Rabitsch, Marco Zecca, Nicolaus Kröger, Claude-Eric Bulabois, Giovanni Grillo, Alessandro Rambaldi, Renato Fanin, Francesco Zallio, Nicola Di Renzo, Yener Koc, Yana Novis, Andrew McDonald, Concepcion Herrera Arroyo, Jaime Sanz, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Publikováno v:
HemaSphere, Vol 7, Iss 7, p e920 (2023)
Availability of haploidentical donors has broadened utilization of allogeneic hematopoietic cell transplantation (allo-HCT). Peripheral blood stem cells (PBSC) are being used with increased frequency in haploidentical allo-HCT. We evaluated extent of
Externí odkaz:
https://doaj.org/article/a86fb26892d24374b8fde8eaa22d0625
Autor:
Heikki Kuusanmäki, Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta, Amanda Ranta, Jani Huuhtanen, Minna Suvela, Alun Parsons, Annasofia Holopainen, Anu Partanen, Milla E.L. Kuusisto, Sirpa Koskela, Riikka Räty, Maija Itälä-Remes, Imre Västrik, Olli Dufva, Sanna Siitonen, Kimmo Porkka, Krister Wennerberg, Caroline A. Heckman, Pia Ettala, Marja Pyörälä, Johanna Rimpiläinen, Timo Siitonen, Mika Kontro
Publikováno v:
Haematologica, Vol 108, Iss 7 (2022)
The BCL-2 inhibitor venetoclax has revolutionized the treatment of acute myeloid leukemia (AML) in patients not benefiting from intensive chemotherapy. Nevertheless, treatment failure remains a challenge, and predictive markers are needed, particular
Externí odkaz:
https://doaj.org/article/ed146fcdf2474b39baf1bf345a6c2b2c
Autor:
Helena Hohtari, Niels Pallisgaard, Matti Kankainen, Pekka Ellonen, Oscar Brück, Timo Siitonen, Marjaana Säily, Marjatta Sinisalo, Marja Pyörälä, Maija Itälä-Remes, Perttu Koskenvesa, Erkki Elonen, Satu Mustjoki, Kimmo Porkka
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/5387630602a9470ab1aafc96dd4f32f5
Autor:
Daehong Kim, Giljun Park, Jani Huuhtanen, Sofie Lundgren, Rajiv K. Khajuria, Ana M. Hurtado, Cecilia Muñoz-Calleja, Laura Cardeñoso, Valle Gómez-García de Soria, Tzu Hua Chen-Liang, Samuli Eldfors, Pekka Ellonen, Sari Hannula, Matti Kankainen, Oscar Bruck, Anna Kreutzman, Urpu Salmenniemi, Tapio Lönnberg, Andrés Jerez, Maija Itälä-Remes, Mikko Myllymäki, Mikko A. I. Keränen, Satu Mustjoki
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Chronic graft versus host disease (cGvHD) is a major cause of morbidity and mortality in allogeneic bone marrow transplantation. Here the authors identify a recurrent activating mTOR mutation in expanded donor T-cell clones of 3 cGvHD patients, which
Externí odkaz:
https://doaj.org/article/ea0ed950dd9b43599b0f71b6f958e251
Autor:
Kati Hyvärinen, Satu Koskela, Riitta Niittyvuopio, Anne Nihtinen, Liisa Volin, Urpu Salmenniemi, Mervi Putkonen, Ismael Buño, David Gallardo, Maija Itälä-Remes, Jukka Partanen, Jarmo Ritari
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Graft-vs.-host disease (GvHD) is a major complication after allogeneic hematopoietic stem cell transplantation that causes mortality and severe morbidity. Genetic disparities in human leukocyte antigens between the recipient and donor are known contr
Externí odkaz:
https://doaj.org/article/5a01dc7926d04cf7b717b130211e553b
Autor:
Vesa Lindström, Janne Aittoniemi, Urpu Salmenniemi, Helena Käyhty, Heini Huhtala, Maija Itälä-Remes, Marjatta Sinisalo
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 6, Pp 1471-1474 (2018)
Patients with chronic lymphocytic leukemia (CLL) are at a high risk for infections caused by Streptococcus pneumoniae. A pneumococcal conjugate vaccine (PCV) can induce a significant antibody response for some CLL patients. In this study we investiga
Externí odkaz:
https://doaj.org/article/be5d4bcbfddb4bd0a76dbdace697f96b
Autor:
Joni Keto, Tanja Kaartinen, Urpu Salmenniemi, Johanna Castrén, Jukka Partanen, Arno Hänninen, Matti Korhonen, Kaarina Lähteenmäki, Maija Itälä-Remes, Johanna Nystedt
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 9, Iss , Pp 109-118 (2018)
Mesenchymal stromal cells (MSCs) are used as salvage therapy to treat steroid-refractory acute graft-versus-host disease (aGvHD). We studied the immunological response to MSC treatment in 16 aGvHD patients by assessing lymphocyte profiles and three p
Externí odkaz:
https://doaj.org/article/10f41fb7114346d583caa5327b369bf7